---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284251391.md"
description: "Adagio Medical Holdings shares are trading lower. The company presented six-month results from its FULCRUM-VT Investigational Device Exemption clinical trial."
datetime: "2026-04-27T16:32:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284251391.md)
  - [en](https://longbridge.com/en/news/284251391.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284251391.md)
---

# 

Adagio Medical Holdings shares are trading lower. The company presented six-month results from its FULCRUM-VT Investigational Device Exemption clinical trial.

### Related Stocks

- [ADGM.US](https://longbridge.com/en/quote/ADGM.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)

## Related News & Research

- [Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress | ADGM Stock News](https://longbridge.com/en/news/286095782.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)
- [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md)
- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)